Dear Doctor Letter (Rote-Hand-Brief) on Hexvix®: Visual inspection of vials prior to administration
2011.12.29
Active substance: hexaminolevulinate hydrochloride
Ipsen Pharma GmbH advises healthcare professionals to visually inspect the Hexvix® vials prior to administration in order to exclude particle contamination. Furthermore, suspected cases of sepsis should be reported along with the numbers of the suspected batch(es).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN